Birdwatch Note
2024-04-30 13:24:18 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Esto es falso. Los coágulos de sangre son un efecto secundario extremadamente raro de esta vacuna, se informó por primera vez en 2021, cuando comenzó la campaña de vacunación. Astra Zeneca acaba de repetirlo ante el tribunal y se tergiversa como una confesión forzada. https://www.nytimes.com/2021/04/10/health/astrazeneca-vaccine-blood-clots.html
Written by 93732E3FECC4A1B96433A2334D18BF58E46D82C5AD41019CA1C0B34A8E10C750
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1785263208434962668
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1785299136780116122
- noteId - 1785299136780116122
- participantId -
- noteAuthorParticipantId - 93732E3FECC4A1B96433A2334D18BF58E46D82C5AD41019CA1C0B34A8E10C750
- createdAtMillis - 1714483458120
- tweetId - 1785263208434962668
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Esto es falso. Los coágulos de sangre son un efecto secundario extremadamente raro de esta vacuna, se informó por primera vez en 2021, cuando comenzó la campaña de vacunación. Astra Zeneca acaba de repetirlo ante el tribunal y se tergiversa como una confesión forzada. https://www.nytimes.com/2021/04/10/health/astrazeneca-vaccine-blood-clots.html
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-04-30 13:24:18 UTC (1714483458120) |
2024-04-30 17:33:04 UTC (1714498384835) |
CURRENTLY_RATED_HELPFUL | 2024-05-01 12:35:12 UTC (1714566912495) |
CURRENTLY_RATED_HELPFUL | 2024-04-30 17:33:04 UTC (1714498384835) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-04-30 18:13:01 -0500 | Rating Details | |
2024-04-30 15:32:03 -0500 | Rating Details | |
2024-04-30 15:21:54 -0500 | Rating Details | |
2024-04-30 14:52:23 -0500 | Rating Details | |
2024-04-30 14:30:23 -0500 | Rating Details | |
2024-04-30 13:56:24 -0500 | Rating Details | |
2024-04-30 13:14:15 -0500 | Rating Details | |
2024-04-30 13:09:13 -0500 | Rating Details | |
2024-04-30 12:40:06 -0500 | Rating Details | |
2024-04-30 12:26:20 -0500 | Rating Details | |
2024-04-30 12:11:03 -0500 | Rating Details | |
2024-04-30 11:51:33 -0500 | Rating Details | |
2024-04-30 11:37:40 -0500 | Rating Details | |
2024-04-30 11:21:51 -0500 | Rating Details | |
2024-04-30 11:19:09 -0500 | Rating Details | |
2024-04-30 11:14:08 -0500 | Rating Details | |
2024-04-30 11:13:30 -0500 | Rating Details | |
2024-04-30 11:05:22 -0500 | Rating Details | |
2024-04-30 10:58:05 -0500 | Rating Details | |
2024-04-30 10:43:39 -0500 | Rating Details | |
2024-04-30 10:43:34 -0500 | Rating Details | |
2024-04-30 10:27:33 -0500 | Rating Details | |
2024-04-30 10:27:32 -0500 | Rating Details | |
2024-04-30 10:23:35 -0500 | Rating Details | |
2024-04-30 10:22:53 -0500 | Rating Details | |
2024-04-30 10:20:49 -0500 | Rating Details | |
2024-04-30 10:18:57 -0500 | Rating Details | |
2024-04-30 10:14:59 -0500 | Rating Details | |
2024-04-30 10:12:04 -0500 | Rating Details | |
2024-04-30 10:09:37 -0500 | Rating Details | |
2024-04-30 10:05:06 -0500 | Rating Details | |
2024-04-30 10:01:10 -0500 | Rating Details | |
2024-04-30 09:58:14 -0500 | Rating Details | |
2024-04-30 09:53:52 -0500 | Rating Details | |
2024-04-30 09:53:01 -0500 | Rating Details | |
2024-04-30 09:50:20 -0500 | Rating Details | |
2024-04-30 09:50:02 -0500 | Rating Details | |
2024-04-30 09:45:33 -0500 | Rating Details | |
2024-04-30 09:42:38 -0500 | Rating Details | |
2024-04-30 09:37:20 -0500 | Rating Details | |
2024-05-01 01:02:35 -0500 | Rating Details | |
2024-04-30 21:59:04 -0500 | Rating Details | |
2024-04-30 19:57:57 -0500 | Rating Details | |
2024-05-02 05:47:27 -0500 | Rating Details | |
2024-05-01 20:40:21 -0500 | Rating Details | |
2024-05-01 03:45:58 -0500 | Rating Details | |
2024-05-01 02:00:26 -0500 | Rating Details | |
2024-04-30 23:21:35 -0500 | Rating Details | |
2024-04-30 22:04:04 -0500 | Rating Details | |
2024-04-30 17:49:38 -0500 | Rating Details | |
2024-04-30 17:07:39 -0500 | Rating Details | |
2024-04-30 16:19:00 -0500 | Rating Details | |
2024-04-30 16:06:38 -0500 | Rating Details | |
2024-04-30 15:32:47 -0500 | Rating Details | |
2024-04-30 14:56:04 -0500 | Rating Details | |
2024-04-30 13:42:07 -0500 | Rating Details | |
2024-04-30 13:39:56 -0500 | Rating Details | |
2024-04-30 13:14:41 -0500 | Rating Details | |
2024-04-30 12:25:38 -0500 | Rating Details | |
2024-04-30 12:20:43 -0500 | Rating Details | |
2024-04-30 11:57:37 -0500 | Rating Details | |
2024-04-30 11:57:09 -0500 | Rating Details | |
2024-04-30 11:50:03 -0500 | Rating Details | |
2024-04-30 11:44:29 -0500 | Rating Details | |
2024-04-30 11:31:32 -0500 | Rating Details | |
2024-04-30 11:16:09 -0500 | Rating Details | |
2024-04-30 11:14:21 -0500 | Rating Details | |
2024-04-30 11:08:59 -0500 | Rating Details | |
2024-04-30 10:55:59 -0500 | Rating Details | |
2024-04-30 10:52:01 -0500 | Rating Details | |
2024-04-30 10:44:44 -0500 | Rating Details | |
2024-04-30 10:36:22 -0500 | Rating Details | |
2024-04-30 10:34:48 -0500 | Rating Details | |
2024-04-30 10:28:16 -0500 | Rating Details | |
2024-04-30 10:22:37 -0500 | Rating Details | |
2024-04-30 10:11:09 -0500 | Rating Details | |
2024-04-30 10:09:20 -0500 | Rating Details | |
2024-04-30 10:08:58 -0500 | Rating Details | |
2024-04-30 10:07:58 -0500 | Rating Details | |
2024-04-30 10:07:43 -0500 | Rating Details | |
2024-04-30 10:07:19 -0500 | Rating Details | |
2024-04-30 10:02:07 -0500 | Rating Details | |
2024-04-30 10:01:19 -0500 | Rating Details | |
2024-04-30 09:56:20 -0500 | Rating Details | |
2024-04-30 09:56:05 -0500 | Rating Details | |
2024-04-30 09:55:21 -0500 | Rating Details | |
2024-04-30 09:55:18 -0500 | Rating Details | |
2024-04-30 09:55:04 -0500 | Rating Details | |
2024-04-30 09:53:28 -0500 | Rating Details | |
2024-04-30 09:52:52 -0500 | Rating Details | |
2024-04-30 09:52:46 -0500 | Rating Details | |
2024-04-30 09:51:55 -0500 | Rating Details | |
2024-04-30 09:42:43 -0500 | Rating Details | |
2024-04-30 09:42:00 -0500 | Rating Details | |
2024-05-03 14:11:40 -0500 | Rating Details | |
2024-05-02 15:08:31 -0500 | Rating Details | |
2024-05-02 11:44:32 -0500 | Rating Details | |
2024-05-02 11:27:45 -0500 | Rating Details | |
2024-05-01 15:31:09 -0500 | Rating Details | |
2024-05-01 13:52:00 -0500 | Rating Details | |
2024-05-01 12:50:54 -0500 | Rating Details | |
2024-05-01 10:21:39 -0500 | Rating Details | |
2024-04-30 23:06:00 -0500 | Rating Details | |
2024-04-30 21:03:19 -0500 | Rating Details | |
2024-04-30 20:45:14 -0500 | Rating Details | |
2024-04-30 20:44:36 -0500 | Rating Details | |
2024-04-30 17:38:25 -0500 | Rating Details | |
2024-04-30 15:52:49 -0500 | Rating Details | |
2024-04-30 15:25:52 -0500 | Rating Details | |
2024-04-30 14:27:55 -0500 | Rating Details | |
2024-04-30 13:17:46 -0500 | Rating Details | |
2024-04-30 13:17:22 -0500 | Rating Details | |
2024-04-30 13:12:53 -0500 | Rating Details | |
2024-04-30 13:01:13 -0500 | Rating Details | |
2024-04-30 12:35:06 -0500 | Rating Details | |
2024-04-30 12:02:39 -0500 | Rating Details | |
2024-04-30 11:47:46 -0500 | Rating Details | |
2024-04-30 11:47:30 -0500 | Rating Details | |
2024-04-30 11:46:57 -0500 | Rating Details | |
2024-04-30 11:32:50 -0500 | Rating Details | |
2024-04-30 10:56:33 -0500 | Rating Details | |
2024-04-30 10:53:12 -0500 | Rating Details | |
2024-04-30 10:52:25 -0500 | Rating Details | |
2024-04-30 10:49:37 -0500 | Rating Details | |
2024-04-30 10:48:05 -0500 | Rating Details | |
2024-04-30 10:45:34 -0500 | Rating Details | |
2024-04-30 10:38:21 -0500 | Rating Details | |
2024-04-30 10:30:41 -0500 | Rating Details | |
2024-04-30 10:29:25 -0500 | Rating Details | |
2024-04-30 10:19:30 -0500 | Rating Details | |
2024-04-30 10:11:33 -0500 | Rating Details | |
2024-04-30 10:10:24 -0500 | Rating Details | |
2024-04-30 10:09:47 -0500 | Rating Details | |
2024-04-30 10:03:15 -0500 | Rating Details | |
2024-04-30 09:57:14 -0500 | Rating Details | |
2024-04-30 09:55:24 -0500 | Rating Details | |
2024-04-30 09:54:12 -0500 | Rating Details | |
2024-04-30 09:54:00 -0500 | Rating Details | |
2024-04-30 09:53:56 -0500 | Rating Details | |
2024-04-30 09:52:58 -0500 | Rating Details | |
2024-04-30 09:41:04 -0500 | Rating Details | |
2024-04-30 09:40:15 -0500 | Rating Details | |
2024-04-30 09:39:01 -0500 | Rating Details | |
2024-05-02 08:33:18 -0500 | Rating Details | |
2024-05-02 08:31:14 -0500 | Rating Details | |
2024-05-02 06:15:56 -0500 | Rating Details | |
2024-05-02 05:50:21 -0500 | Rating Details | |
2024-05-03 10:01:13 -0500 | Rating Details | |
2024-05-01 18:45:25 -0500 | Rating Details | |
2024-05-01 11:24:12 -0500 | Rating Details | |
2024-05-01 05:11:13 -0500 | Rating Details | |
2024-05-01 02:52:02 -0500 | Rating Details | |
2024-05-01 02:39:12 -0500 | Rating Details | |
2024-04-30 23:09:43 -0500 | Rating Details | |
2024-04-30 22:10:08 -0500 | Rating Details | |
2024-04-30 20:41:08 -0500 | Rating Details | |
2024-04-30 20:35:03 -0500 | Rating Details | |
2024-04-30 19:32:38 -0500 | Rating Details | |
2024-04-30 18:05:00 -0500 | Rating Details | |
2024-04-30 17:27:45 -0500 | Rating Details | |
2024-04-30 15:28:06 -0500 | Rating Details | |
2024-04-30 15:24:42 -0500 | Rating Details | |
2024-04-30 15:13:37 -0500 | Rating Details | |
2024-04-30 14:57:56 -0500 | Rating Details | |
2024-04-30 13:57:56 -0500 | Rating Details | |
2024-04-30 13:20:07 -0500 | Rating Details | |
2024-04-30 13:01:59 -0500 | Rating Details | |
2024-04-30 12:48:15 -0500 | Rating Details | |
2024-04-30 12:31:23 -0500 | Rating Details | |
2024-04-30 12:20:56 -0500 | Rating Details | |
2024-04-30 12:19:55 -0500 | Rating Details | |
2024-04-30 12:10:09 -0500 | Rating Details | |
2024-04-30 11:44:39 -0500 | Rating Details | |
2024-04-30 11:29:39 -0500 | Rating Details | |
2024-04-30 11:15:00 -0500 | Rating Details | |
2024-04-30 11:04:32 -0500 | Rating Details | |
2024-04-30 10:57:11 -0500 | Rating Details | |
2024-04-30 10:52:44 -0500 | Rating Details | |
2024-04-30 10:31:08 -0500 | Rating Details | |
2024-04-30 10:16:38 -0500 | Rating Details | |
2024-04-30 10:13:04 -0500 | Rating Details | |
2024-04-30 10:00:40 -0500 | Rating Details | |
2024-04-30 09:59:52 -0500 | Rating Details | |
2024-04-30 09:59:42 -0500 | Rating Details | |
2024-04-30 09:57:51 -0500 | Rating Details | |
2024-04-30 09:57:45 -0500 | Rating Details | |
2024-04-30 09:57:18 -0500 | Rating Details | |
2024-04-30 09:56:48 -0500 | Rating Details | |
2024-04-30 09:55:12 -0500 | Rating Details | |
2024-04-30 09:52:53 -0500 | Rating Details | |
2024-04-30 09:51:46 -0500 | Rating Details | |
2024-04-30 09:50:21 -0500 | Rating Details | |
2024-04-30 09:42:10 -0500 | Rating Details | |
2024-04-30 09:02:22 -0500 | Rating Details | |
2024-04-30 08:54:27 -0500 | Rating Details | |
2024-05-01 16:55:09 -0500 | Rating Details | |
2024-05-01 12:58:03 -0500 | Rating Details | |
2024-04-30 14:49:07 -0500 | Rating Details | |
2024-04-30 13:51:59 -0500 | Rating Details | |
2024-04-30 13:13:12 -0500 | Rating Details | |
2024-04-30 10:19:38 -0500 | Rating Details | |
2024-09-14 05:02:02 -0500 | Rating Details |